was performed. Over the study period 537 heart donors were identified, of which 321 (60%) were transplanted. Two hundred-sixteen consented hearts were not used; 190 of these were not recovered, and 26 were recovered but not transplanted. Of these, 245/321 (76%) hearts were transplanted at one of 5 regional programs, 15 (5%) were transplanted out of region as primary offers, and 61 (19%) were turned down in region and exported. Of the 61 exported hearts, 43 were turned down in region for donor-related "quality" codes (UNOS 830,(833)(834)(835)(836)(837) by at least one program, the remaining 18 hearts were turned down for non-"quality" reasons, primarily histocompatibility and size. Only 5/43 exported were turned down for "quality" reasons by all regional programs offered the organ. A review of consented, not recovered donor offers suggested an additional 28 organs were possibly appropriate for transplant. Our review of regional turn-downs suggests transplant centers could potentially identify additional usable organs without compromising short-term outcomes.
includes the five heart transplant programs in UNOS Region 9, collaborated with the four regional Organ Procurement Organizations (OPOs) to retrospectively examine all heart donor offers over a 4-year period from 2010-2013 to determine if there was optimal donor heart utilization. We sought to identify opportunities to increase local organ recovery use, improve OPO relationships with local heart transplant programs, and to determine if changes in acceptance practices needed to be made in the region. We hypothesized that this type of analysis though focused on a local busy UNOS region could ultimately impact not only local practice but the lessons learned could serve to educate other UNOS regions.
| METHODS

| Data collection
This was a retrospective review of data on all adult heart donor offers reviewed. The sequence number at which the heart was either transplanted or discarded was also included. For all transplanted organs, the location of transplant was determined and recipient outcome information was obtained for hearts exported out of region. DonorNet records for the 216 discarded organs were also reviewed. The same donor variables were collected for the discarded organs as were collected for the transplanted organs, including disposition codes and placement attempts.
Transplant center refusal codes and OPO disposition codes were grouped into similar categories. Of the 37 potential transplant recipient refusal codes, those categories associated with poor donor quality were combined (UNOS code 830, 833-837). Of the 49 OPO disposition codes, codes for poor graft function such as poor organ function (200), cardiac arrest (201), diseased organ (205), ejection fraction <50% (220), and turned down in OR (503) were also combined (Table 1) . 
| Donor management
| Data analysis
| RESULTS
Over the 4 years studied, there were 537 New York State heart donors offered for transplant ( Figure 1 Closer examination of these 61 exported hearts revealed 43 were turned down in NYS for a donor-related "quality" reason (UNOS codes 830, 833-37 - Table 2 ) by at least 1 program, but only 5 of those 43
were turned down for quality reasons by all programs that were offered the organ. Other refusal codes entered for these exported hearts included histocompatibility-related reasons (810-15) in 9 patients, donor size/weight (831) for another 9 patients. Ten donors were excluded for both histocompatibility and size/weight, and 10 for recipient-related reasons (800-03).
Donor characteristics of those organs transplanted in and out of region are shown in Table 3 . Mean age of the 43 donors was 41 years (Range 19-61). Most donors were blood type O (51%), followed by A (33%), B (14%), and AB (2%). Primary donor causes of death were drug/anoxia (37%), head trauma (33%), and intracranial hemorrhage or cerebral vascular event (30%). Thirty-eight percent had downtime (R 3-60 mins) and 19% were PHS (Public Health Service) high risk.
The majority (81%) had an EF ≥55%, and 64% had an abnormal ECG.
The hearts exported out of region tended to be older and more often blood type B or AB. The 1-year graft survival for the 43 exported hearts was 88% which is comparable to current 1-year survival post cardiac transplantation.
| Discarded organs
Approximately 40% of the donor hearts identified were not used.
There were 190 (35%) hearts that were not recovered, primarily due to poor organ function and abnormal test results; and 26 (5%) hearts were recovered but not transplanted due to organ-related issues.
The OPO discard codes are shown in Table 1 . The clinical characteristics of the discarded hearts are shown in Table 4 . Many organs were turned down for poor organ function but for a large number of organs a simple refusal by a national or regional program was all that was registered. Moreover, many of the discarded organs were listed as referred for research or heart valves. Accordingly, the DonorNet records for these discards were reviewed. 
| DISCUSSION
As the median waiting time for heart transplantation in Region 9 is 11.1 months (SRTR, 2016), compared to the national wait of 
2.
Of the hearts turned down by Region 9 centers for quality and transplanted out of region, the 1-year survival of these organs was comparable to national statistics.
3.
Of the 216 organs discarded by all programs, after in-depth review using commonly used donor screening criteria, an additional 28 organs may have been suitable for waiting list patients.
In the current medical marketplace, heart transplant centers are under pressure to provide excellent short-term outcomes in order to comply with regulatory agency reviews and to compete for coveted 
Hearts transplanted out of region (N = 76)
Hearts rejected for quality (N = 43) P-value using extended criteria donors for patients on alternative transplant lists. 9, 10 Despite this liberalization of donor criteria by some centers, other centers have become more conservative in their donor acceptance practices due to the widespread availability of mechanical assist devices which provide excellent bridges to transplant and thus enable less risk taking. Also, the use of LVADs has complicated transplant surgery with more frequent bleeding, need for transfusions and vasoplegia, all of which place additional burdens on the allograft. Transplant programs are hesitant to compound risks and compromise surgical outcomes and therefore are reluctant to use a higher risk donor allograft for a higher risk recipient. Whether stable device patients should be passed over for a less suitable organ is uncertain as these recipients are at risk for potentially life threatening device complications which may contribute to post transplant morbidity or mortality.
Additional considerations for donor placement include size matching of the donor and recipient. Generally, a donor within 20% range of height/weight of the recipient is acceptable though practices vary.
One of the principal reasons for donor export in our region was size concerns.
The acceptance of virtual crossmatching to allow broader organ sharing is also not a uniform practice among centers, 6-8 but again histocompatibility reasons were the other leading cause for organ export.
| Donor selection optimization
There are several ways the heart transplant community can act to better utilize donor offers:
1. Application of donor risk scores for more objective donor screening. Though donor risk scores such as Eurotransplant Heart Donor Score consisting of 12 donor variables 11 or the UNOS Donor Risk Score which incorporate four variables 12 are available, this objective approach to donor screening has not been widely applied in the cardiac community. In contrast the kidney donor profile index has been integrated into the renal transplant allocation scheme. To increase donor utilization, the cardiology community could consider using more objective criteria 13, 14 ; however, these scoring systems have not been validated and significant differences in recipient characteristics exist between the different UNOS regions. Despite all these potential solutions, we must acknowledge that the donor pool remains too small for the current and future needs of cardiac transplantation, and we must all work at both expanding the donor pool and limiting the growth of the present waitlist.
| Limitations
There are several limitations to this study. A major limitation is inaccuracies regarding donor acceptance and refusal as reported in 
